Central and peripheral nervous system dysfunction in the clinical variation of Salla disease
- PMID: 10891913
- DOI: 10.1212/wnl.55.1.99
Central and peripheral nervous system dysfunction in the clinical variation of Salla disease
Abstract
Objective: To evaluate the degree of possible peripheral nervous system (PNS) involvement in addition to CNS manifestations in Salla disease, a free sialic acid storage disorder leading to severe mental retardation with a wide clinical variation.
Background: Salla disease is a lysosomal storage disorder that affects the white matter of the CNS. MRI findings and recent 1H MRS study results provide evidence for delayed central myelination, but there is no previous evidence for PNS involvement in this disease. The gene coding for a presumptive sialic acid transport protein has recently been identified, and the first disease-causing mutations have been characterized.
Methods: Nerve conduction studies; evoked potentials to visual (VEP), brainstem auditory (BAEP), and somatosensory stimuli (SEP); and EEG were carried out on 22 patients (age range 2 months to 57 years) with biochemically and genetically confirmed Salla disease. Brain MRI were available on 14 patients.
Results: Nerve conduction studies revealed abnormalities in nearly half of the patients (10/21). The four severely disabled patients and the oldest patient had greatly reduced nerve conduction velocities and prolonged distal latencies compatible with demyelinating polyneuropathy. In addition, SEP was abnormal in the majority of the patients, but VEP and BAEP in only a few cases. PNS involvement was clearly associated with both the phenotypic severity and MRI findings.
Conclusions: The results indicate that dysmyelination in Salla disease occurs not only in the CNS but also in the peripheral nervous system, contributing to the phenotypic variation, which can now be correlated with the molecular basis of the disease.
Similar articles
-
Unusual neurophysiological features in Cockayne's syndrome: a report of two cases as a contribution to diagnosis and classification.Brain Dev. 2004 Jun;26(4):273-80. doi: 10.1016/S0387-7604(03)00130-X. Brain Dev. 2004. PMID: 15130695
-
A distinct subgroup of chronic inflammatory demyelinating polyneuropathy with CNS demyelination and a favorable response to immunotherapy.J Neurol Sci. 2007 Apr 15;255(1-2):1-6. doi: 10.1016/j.jns.2007.01.004. Epub 2007 Feb 15. J Neurol Sci. 2007. PMID: 17306302
-
Central and peripheral nervous system conduction in mitochondrial myopathy with chronic progressive external ophthalmoplegia.Electroencephalogr Clin Neurophysiol. 1994 Apr;90(4):304-12. doi: 10.1016/0013-4694(94)90149-x. Electroencephalogr Clin Neurophysiol. 1994. PMID: 7512912
-
Subclinical neurophysiological effects of lead: A review on peripheral, central, and autonomic nervous system effects in lead workers.Am J Ind Med. 2000 Feb;37(2):193-204. doi: 10.1002/(sici)1097-0274(200002)37:2<193::aid-ajim5>3.0.co;2-j. Am J Ind Med. 2000. PMID: 10615100 Review.
-
Central nervous system therapy for lysosomal storage disorders.Neurosurg Focus. 2008;24(3-4):E12. doi: 10.3171/FOC/2008/24/3-4/E11. Neurosurg Focus. 2008. PMID: 18341388 Review.
Cited by
-
Decreased T2 signal in the thalami may be a sign of lysosomal storage disease.Neuroradiology. 2007 Jul;49(7):571-8. doi: 10.1007/s00234-007-0220-6. Epub 2007 Mar 3. Neuroradiology. 2007. PMID: 17334752 Review.
-
A 13-year follow-up of Finnish patients with Salla disease.J Neurodev Disord. 2015;7(1):20. doi: 10.1186/s11689-015-9116-7. Epub 2015 Jul 13. J Neurodev Disord. 2015. PMID: 26171070 Free PMC article.
-
Homozygosity for the p.K136E mutation in the SLC17A5 gene as cause of an Italian severe Salla disease.Neurogenetics. 2005 Dec;6(4):195-9. doi: 10.1007/s10048-005-0011-3. Epub 2005 Sep 17. Neurogenetics. 2005. PMID: 16170568
-
Hyccin, the molecule mutated in the leukodystrophy hypomyelination and congenital cataract (HCC), is a neuronal protein.PLoS One. 2012;7(3):e32180. doi: 10.1371/journal.pone.0032180. Epub 2012 Mar 26. PLoS One. 2012. PMID: 22461884 Free PMC article.
-
Novel Therapeutic Approaches in Inherited Neuropathies: A Systematic Review.Pharmaceutics. 2023 May 30;15(6):1626. doi: 10.3390/pharmaceutics15061626. Pharmaceutics. 2023. PMID: 37376074 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources